Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay: results from the GEOMETRY mono-1 study

J. Wolf, E. B. Garon, D. S. -W Tan, H. J. M. Groen, T. Seto, E. F. Smit, M. Zou, Y. Yang, Y. Li, A. Chassot-Agostinho, R. S. Heist


Originele taal-2English
Pagina's (van-tot)5-5
Aantal pagina's1
TijdschriftOncology Research and Treatment
StatusPublished - sep.-2021

Citeer dit